ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 634

Targeted 1H NMR Based Metabolomics Analysis Revealed Significantly Higher Synovial Phe/Tyr Ratio in Reactive Arthritis and Undifferentiated Spondyloarthropathy

Hafis Muhammed1, Dinesh Kumar 2, Durgesh Dubey 2, Sandeep Kumar 3, Smriti Chaurasia 3, Anupam Guleria 2, Sanjukta Majumder 3, Rajeev Singh 3, Vikas Agarwal 1 and Ramnath Misra 4, 1SGPGI, Lucknow, Uttar Pradesh, India, 2Centre for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, Uttar Pradesh, India, 3Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, Uttar Pradesh, India

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: reactive arthritis and metabolomics, Spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Elevated phenylalanine-to-tyrosine ratio (Phe/Tyr) is a marker of oxidative stress. We hypothesized that the synovial Phe/Tyr in reactive arthritis is higher than Rheumatoid arthritis(RA) and osteoarthritis(OA). We conducted this study with the objective to compare the synovial Phe/Tyr between ReA/uSpA and RA and OA by NMR spectroscopy

Methods: Paired synovial fluid and serum of 30 patients with ReA/uSpA were collected and analysed using a 1D 1H CPMG NMR spectra recorded on 800 MHz NMR spectrometer equipped with a TCI Cryoprobe (at 300 k).  Phenylalanine and tyrosine were quantified. Synovial fluid from 25 patients with RA fulfilling ACR classification criteria and 21 patients with OA were taken as inflammatory and non-inflammatory controls.

Results: Synovial Phe/Tyr ratio was significantly higher in ReA/uSpA compared to RA and OA. Synovial Phe/Tyr ratios were comparable in RA and OA patients. Compared to serum, the Phe/Tyr was significantly higher in the SF in ReA/uSpA. The Phe/Tyr was also found to be positively correlated between serum and SF samples with regression coefficient (r2) of 0.287.

Conclusion: NMR based metabolomics study demonstrates that the synovial Phe/Tyr are specifically elevated in ReA/uSpA.

Synovial Phe/Tyr ratio was significantly higher in ReA/uSpA compared to RA and OA


Disclosure: H. Muhammed, None; D. Kumar, None; D. Dubey, None; S. Kumar, None; S. Chaurasia, None; A. Guleria, None; S. Majumder, None; R. Singh, None; V. Agarwal, None; R. Misra, None.

To cite this abstract in AMA style:

Muhammed H, Kumar D, Dubey D, Kumar S, Chaurasia S, Guleria A, Majumder S, Singh R, Agarwal V, Misra R. Targeted 1H NMR Based Metabolomics Analysis Revealed Significantly Higher Synovial Phe/Tyr Ratio in Reactive Arthritis and Undifferentiated Spondyloarthropathy [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/targeted-1h-nmr-based-metabolomics-analysis-revealed-significantly-higher-synovial-phe-tyr-ratio-in-reactive-arthritis-and-undifferentiated-spondyloarthropathy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeted-1h-nmr-based-metabolomics-analysis-revealed-significantly-higher-synovial-phe-tyr-ratio-in-reactive-arthritis-and-undifferentiated-spondyloarthropathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology